Copyright Reports & Markets. All rights reserved.

Global Influenza Diagnostics Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Influenza Diagnostics by Type
    • 1.3.1 Overview: Global Influenza Diagnostics Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Influenza Diagnostics Consumption Value Market Share by Type in 2024
    • 1.3.3 RIDT
    • 1.3.4 RT-PCR
    • 1.3.5 Cell Culture
    • 1.3.6 Others
  • 1.4 Global Influenza Diagnostics Market by Application
    • 1.4.1 Overview: Global Influenza Diagnostics Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospitals
    • 1.4.3 POCT
    • 1.4.4 Others
  • 1.5 Global Influenza Diagnostics Market Size & Forecast
  • 1.6 Global Influenza Diagnostics Market Size and Forecast by Region
    • 1.6.1 Global Influenza Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Influenza Diagnostics Market Size by Region, (2020-2031)
    • 1.6.3 North America Influenza Diagnostics Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Influenza Diagnostics Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Influenza Diagnostics Market Size and Prospect (2020-2031)
    • 1.6.6 South America Influenza Diagnostics Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Influenza Diagnostics Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 BD
    • 2.1.1 BD Details
    • 2.1.2 BD Major Business
    • 2.1.3 BD Influenza Diagnostics Product and Solutions
    • 2.1.4 BD Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 BD Recent Developments and Future Plans
  • 2.2 Abbott (Include Alere)
    • 2.2.1 Abbott (Include Alere) Details
    • 2.2.2 Abbott (Include Alere) Major Business
    • 2.2.3 Abbott (Include Alere) Influenza Diagnostics Product and Solutions
    • 2.2.4 Abbott (Include Alere) Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Abbott (Include Alere) Recent Developments and Future Plans
  • 2.3 Roche
    • 2.3.1 Roche Details
    • 2.3.2 Roche Major Business
    • 2.3.3 Roche Influenza Diagnostics Product and Solutions
    • 2.3.4 Roche Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Roche Recent Developments and Future Plans
  • 2.4 SIEMENS
    • 2.4.1 SIEMENS Details
    • 2.4.2 SIEMENS Major Business
    • 2.4.3 SIEMENS Influenza Diagnostics Product and Solutions
    • 2.4.4 SIEMENS Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 SIEMENS Recent Developments and Future Plans
  • 2.5 Analytik Jena
    • 2.5.1 Analytik Jena Details
    • 2.5.2 Analytik Jena Major Business
    • 2.5.3 Analytik Jena Influenza Diagnostics Product and Solutions
    • 2.5.4 Analytik Jena Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Analytik Jena Recent Developments and Future Plans
  • 2.6 Quidel
    • 2.6.1 Quidel Details
    • 2.6.2 Quidel Major Business
    • 2.6.3 Quidel Influenza Diagnostics Product and Solutions
    • 2.6.4 Quidel Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Quidel Recent Developments and Future Plans
  • 2.7 Thermo Fisher
    • 2.7.1 Thermo Fisher Details
    • 2.7.2 Thermo Fisher Major Business
    • 2.7.3 Thermo Fisher Influenza Diagnostics Product and Solutions
    • 2.7.4 Thermo Fisher Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Thermo Fisher Recent Developments and Future Plans
  • 2.8 Meridian Bioscience
    • 2.8.1 Meridian Bioscience Details
    • 2.8.2 Meridian Bioscience Major Business
    • 2.8.3 Meridian Bioscience Influenza Diagnostics Product and Solutions
    • 2.8.4 Meridian Bioscience Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Meridian Bioscience Recent Developments and Future Plans
  • 2.9 BioMerieux
    • 2.9.1 BioMerieux Details
    • 2.9.2 BioMerieux Major Business
    • 2.9.3 BioMerieux Influenza Diagnostics Product and Solutions
    • 2.9.4 BioMerieux Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 BioMerieux Recent Developments and Future Plans
  • 2.10 Sekisui Diagnostics
    • 2.10.1 Sekisui Diagnostics Details
    • 2.10.2 Sekisui Diagnostics Major Business
    • 2.10.3 Sekisui Diagnostics Influenza Diagnostics Product and Solutions
    • 2.10.4 Sekisui Diagnostics Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Sekisui Diagnostics Recent Developments and Future Plans
  • 2.11 Response Biomedical
    • 2.11.1 Response Biomedical Details
    • 2.11.2 Response Biomedical Major Business
    • 2.11.3 Response Biomedical Influenza Diagnostics Product and Solutions
    • 2.11.4 Response Biomedical Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Response Biomedical Recent Developments and Future Plans
  • 2.12 SA Scientific
    • 2.12.1 SA Scientific Details
    • 2.12.2 SA Scientific Major Business
    • 2.12.3 SA Scientific Influenza Diagnostics Product and Solutions
    • 2.12.4 SA Scientific Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 SA Scientific Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Influenza Diagnostics Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Influenza Diagnostics by Company Revenue
    • 3.2.2 Top 3 Influenza Diagnostics Players Market Share in 2024
    • 3.2.3 Top 6 Influenza Diagnostics Players Market Share in 2024
  • 3.3 Influenza Diagnostics Market: Overall Company Footprint Analysis
    • 3.3.1 Influenza Diagnostics Market: Region Footprint
    • 3.3.2 Influenza Diagnostics Market: Company Product Type Footprint
    • 3.3.3 Influenza Diagnostics Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Influenza Diagnostics Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Influenza Diagnostics Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Influenza Diagnostics Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Influenza Diagnostics Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Influenza Diagnostics Consumption Value by Type (2020-2031)
  • 6.2 North America Influenza Diagnostics Market Size by Application (2020-2031)
  • 6.3 North America Influenza Diagnostics Market Size by Country
    • 6.3.1 North America Influenza Diagnostics Consumption Value by Country (2020-2031)
    • 6.3.2 United States Influenza Diagnostics Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Influenza Diagnostics Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Influenza Diagnostics Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Influenza Diagnostics Consumption Value by Type (2020-2031)
  • 7.2 Europe Influenza Diagnostics Consumption Value by Application (2020-2031)
  • 7.3 Europe Influenza Diagnostics Market Size by Country
    • 7.3.1 Europe Influenza Diagnostics Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Influenza Diagnostics Market Size and Forecast (2020-2031)
    • 7.3.3 France Influenza Diagnostics Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Influenza Diagnostics Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Influenza Diagnostics Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Influenza Diagnostics Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Influenza Diagnostics Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Influenza Diagnostics Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Influenza Diagnostics Market Size by Region
    • 8.3.1 Asia-Pacific Influenza Diagnostics Consumption Value by Region (2020-2031)
    • 8.3.2 China Influenza Diagnostics Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Influenza Diagnostics Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Influenza Diagnostics Market Size and Forecast (2020-2031)
    • 8.3.5 India Influenza Diagnostics Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Influenza Diagnostics Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Influenza Diagnostics Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Influenza Diagnostics Consumption Value by Type (2020-2031)
  • 9.2 South America Influenza Diagnostics Consumption Value by Application (2020-2031)
  • 9.3 South America Influenza Diagnostics Market Size by Country
    • 9.3.1 South America Influenza Diagnostics Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Influenza Diagnostics Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Influenza Diagnostics Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Influenza Diagnostics Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Influenza Diagnostics Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Influenza Diagnostics Market Size by Country
    • 10.3.1 Middle East & Africa Influenza Diagnostics Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Influenza Diagnostics Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Influenza Diagnostics Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Influenza Diagnostics Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Influenza Diagnostics Market Drivers
  • 11.2 Influenza Diagnostics Market Restraints
  • 11.3 Influenza Diagnostics Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Influenza Diagnostics Industry Chain
  • 12.2 Influenza Diagnostics Upstream Analysis
  • 12.3 Influenza Diagnostics Midstream Analysis
  • 12.4 Influenza Diagnostics Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Influenza Diagnostics market size was valued at US$ 2713 million in 2024 and is forecast to a readjusted size of USD 4102 million by 2031 with a CAGR of 6.2% during review period.
    Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).
    North America is the largest consumption place, with a consumption marker share nearly 53%. Following North America, Europe is the second largest consumption place with the consumption market share of 25%.
    The main manufacturers are BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific etc. BD is the largest manufacturer with about 19% market share.
    This report is a detailed and comprehensive analysis for global Influenza Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Influenza Diagnostics market size and forecasts, in consumption value ($ Million), 2020-2031
    Global Influenza Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
    Global Influenza Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
    Global Influenza Diagnostics market shares of main players, in revenue ($ Million), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Influenza Diagnostics
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Influenza Diagnostics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience, BioMerieux, Sekisui Diagnostics, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Influenza Diagnostics market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    RIDT
    RT-PCR
    Cell Culture
    Others
    Market segment by Application
    Hospitals
    POCT
    Others
    Market segment by players, this report covers
    BD
    Abbott (Include Alere)
    Roche
    SIEMENS
    Analytik Jena
    Quidel
    Thermo Fisher
    Meridian Bioscience
    BioMerieux
    Sekisui Diagnostics
    Response Biomedical
    SA Scientific
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Influenza Diagnostics product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Influenza Diagnostics, with revenue, gross margin, and global market share of Influenza Diagnostics from 2020 to 2025.
    Chapter 3, the Influenza Diagnostics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Influenza Diagnostics market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Influenza Diagnostics.
    Chapter 13, to describe Influenza Diagnostics research findings and conclusion.

    Buy now